United Therapeutics Corporation Inventory Write-down
United Therapeutics Corporation (UTHR) reported Inventory Write-down of $19.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-05
- United Therapeutics Corporation inventory write-down for the quarter ending 2026-06-30 was $19.20M, a 195.38% increase year-over-year.
- United Therapeutics Corporation inventory write-down for the quarter ending 2026-03-31 was $44.90M, a 398.89% increase year-over-year.
- United Therapeutics Corporation inventory write-down for the quarter ending 2025-06-30 was $6.50M.
- United Therapeutics Corporation inventory write-down for the quarter ending 2025-03-31 was $9.00M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month |
|---|---|---|
| 2026-06-30 | $19.20M 10-Q · filed 2026-08-05 | $64.10M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $44.90M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $6.50M 10-Q · filed 2026-08-05 | $15.50M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $9.00M 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |